1,721
Participants
Start Date
July 31, 2006
Primary Completion Date
May 31, 2011
Study Completion Date
July 31, 2011
Abciximab + UFH
Abciximab (0.25 mg/kg of body weight bolus, followed by a 0.125 µg/kg/minute \[maximum of 10 µg/minute\] infusion for 12 hours)
Bivalirudin
Bivalirudin (intravenous bolus of 0.75 mg/kg prior to the start of the intervention, followed by infusion of 1.75 mg/kg per hour for the duration of the procedure)
Heparin
i.v. bolus of 70 units/kg/body weight of unfractionated heparin
Vivantes Klinikum im Friedrichshain, Berlin
Vivantes Auguste Viktoria Klinikum, Berlin
Vivantes Klinikum Neukoelln, Berlin
Marienhospital Osnabrueck, Osnabrück
Ospedale Cageggi, Florence
Herz-Zentrum Bad Krozingen, Bad Krozingen
Deutsches Herzzentrum Muenchen, Munich
Medizinische Klinik, Klinikum rechts der Isar, München
Herz- und Gefaessklinik, Kardiologie, Bad Neustadt an der Saale
Deutsches Herzzentrum Muenchen
OTHER